VB4-845: Clinical Trials

2 trials of VB4-845, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1

Follow VB4-845: new trials by email Literature Review of VB4-845 trials Research Report on VB4-845

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer
VB4-845 Injection - Non-Muscle Invasive Bladder Cancer
Phase 3UnknownQilu Pharmaceutical Co., Ltd.532021-03-232021-04-26
Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG
Vicinium - Bladder Cancer
Phase 3CompletedSesen Bio, Inc.1332015-08-012023-07-24

Conditions studied

Non-Muscle Invasive Bladder Neoplasms (2)  ·  Urinary Bladder Neoplasms (1)

Sponsors

Qilu Pharmaceutical Co., Ltd. (1)  ·  Sesen Bio, Inc. (1)

Countries

Canada (1)  ·  China (1)  ·  United States (1)

Top investigators

Dingwei Ye, PI (1)  ·  Minori K Rosales, M.D., Ph.D. (1)